Wellness: the state of being in good health, especially as an actively pursued goal.
-
Date: November 01, 2022 Time: 8:00am (PDT), 1:00am (EDT), 4:00pm (CEST) This webinar will focus on sub-micron particle analysis utilizing high sensitivity violet side scatter detection. We w...
Date: November 01, 2022 Time: 7:00am (PDT), 10:00am (EDT), 3:00pm (CET) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data t...
Date: October 26, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) In this webinar, attendees will be provided an overview of the technologies that currently exist for bacterial endotox...
Date: October 13, 2022 Time: 11:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Single-cell atlases mapping immune cells provide hints on how immune cells mature, attenuate, and disseminate through...
Date: October 20, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Over the past three decades, baculovirus expression vector system (BEVS) has become one of the most powerful and robus...
Date: October 20, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CET) Many laboratories around the world have adopted expanded diagnostic testing capabilities to address the coronavirus pan...
Date: October 19, 2022 Time: 12:00pm (PDT), 3:00pm (EDT), 9:00pm (CEST) The capacity and speed of modern DNA sequencing platforms has allowed sequencing to become an integral component of bi...
SARS-CoV-2 spreads through airborne transmission. Aerosols containing live virus are dispersed when an infected person exhales and then continue to accumulate indoors, putting others at risk...
In light of the recent pandemic, less attention has been given to more common viruses like influenza. Scientists believe influenza may have been around before the 16th century and probably c...
Background Protection from SARS-CoV-2 vaccines wanes over time and is compounded by emerging variants including Omicron subvariants. This study evaluated safety and immunogenicity of SARS-Co...
Vaccines against SARS-CoV-2 have been made in a record time. However, although the vaccines that have been deployed have clearly reduced the percentage of severe infections in countries wher...